Effect of a Family Pharmacist System on Medication Adherence of Patients with Dyslipidemia during a COVID-19 Epidemic

Maeda Mamoru, Hasegawa Yoshitaka, Tsukioka Ryota, Oishi Miya

doi:10.1248/yakushi.23-00068

Bibliographic Information

Other Title

かかりつけ薬剤師制度が新型コロナウイルス感染症流行下の脂質異常症患者のアドヒアランスに及ぼす影響
カカリツケヤクザイシセイドガシンガタコロナウイルスカンセンショウリュウコウカノシシツイジョウショウカンジャノアドヒアランスニオヨボスエイキョウ

Search this article

Abstract

<p>The pharmacy pharmacist’s function as a family pharmacist is expected to improve adherence to medication in patients suffering from chronic diseases, including dyslipidemia. This is true even in infectious disease epidemics. In this study, using anonymously processed receipt data from 700 insurance pharmacies in our group, we evaluated medication adherence in patients taking statin drugs before, during the first and second years of coronavirus disease 2019 (COVID-19) epidemic in terms of medication persistence and medication possession, and compared the results between the family pharmacist group (FP group) and non-family pharmacist group (NoFP group). The odds ratios of good medication adherence (medication persistence and medication possession) rates for the FP group relative to the NoFP group were 1.446 [95% confidence interval (CI): 1.210–1.727] in the pre-epidemic period, 1.428 (1.192–1.710) in the first year of the epidemic, and 1.270 (1.113–1.450) in the second year of the epidemic. The FP group was significantly higher in all time periods. Therefore, it is suggested that the family pharmacist function improves adherence to statins not only before but also during the COVID-19 epidemic.</p>

Journal

YAKUGAKU ZASSHI

YAKUGAKU ZASSHI 143 (9), 765-775, 2023-09-01

The Pharmaceutical Society of Japan

Keywords

Details 詳細情報について

Export